SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs Q3 earnings and outlook dominate discussion, with traders focused on subscriber engagement and growth, ad revenue, and the effect of recent layoffs and content-leadership changes. Views are sharply divided: some see low expectations and a chance for a rebound, while others fear further weakness, citing the stocks decline and its recent post-earnings performance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Speculation around a potential buyoutfueled by the CEOs anniversary message and the companys planned ASH presenceis competing with anticipation of a final analysis of SELLASs REGAL Phase 3 trial, last reported at 78 of 80 required events. Some traders read the prolonged trial and managements upbeat tone as encouraging, while others stress that no acquisition, event threshold, or trial result has been confirmed and that the recent price move may be trading without fresh news.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas plan to pursue a public listing for its Monee financial-services arm is fueling debate as shares sell off. Some traders see the separation and uncertain timeline as an overhang that could leave Sea with less valuable businesses, while others argue shareholders could benefit from receiving Monee shares or from the business being valued separately.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is drawing attention for persistent share-price underperformance despite growth in its commercial business, with many traders blaming weak confidence in management and the companys acquisition-focused strategy. The debate centers on debt and dilution concerns versus the potential of upcoming Navenibart and Netherton data to support the pipeline and restore confidence.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp has driven a sharp rally, with traders focused on the cash proceeds and potential balance-sheet and strategic benefits. The reaction is divided: some see a positive reset, while skeptics worry the divestiture removes a meaningful revenue business and leaves weaker operations and debt concerns.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE is selling off despite a quarterly earnings beat and higher full-year guidance, as traders focus on rising costs, weaker cash conversion, lower-margin sales and a loss in its insurance business; some also worry that engines are accumulating at Boeing ahead of aircraft deliveries. The reaction has frustrated bullish traders who see strong demand and orders, while others view the selloff as evidence that profitability and execution matter more than the headline beat.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta is drawing attention as shares rebound while traders look ahead to clinical readouts for its DM1 and FSHD siRNA programs, alongside discussion of Arrowhead data as a possible validation of the technology. Bulls see the pipeline as a potential growth driver, while skeptics say early or preclinical results still need to translate into meaningful patient benefit and question the stocks weak price action.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is being discussed alongside expectations of Republican losses in the midterms and declining confidence in Trump, with many traders blaming the stocks political association and questioning the companys business value. The conversation is predominantly bearish, though some traders see a possible short-term bounce.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 trial of RAP-219 in bipolar mania met its primary and secondary endpoints, driving a sharp burst of bullish attention. Traders are divided over whether the modest placebo-adjusted improvement and safety and discontinuation concerns make the result less compelling, with some viewing it as proof of concept and others expecting the rally to fade.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech-sector rebound is driving attention, with traders describing XBI as breaking out after a sharp pullback and citing renewed buying and possible rotation into biotech. Bulls see a recovery taking hold, while skeptics warn the bounce could fade amid rate and other macro headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Grab These ETFs to Capitalize on the Physical AI Wave

Physical AI is reshaping robotics, autonomous vehicles and smart manufacturing. Discover three ETFs offering diversified exposure to this fast-growing market.

Jensen Huang Calls OpenAI ‘One Of The Most Consequential Companies In History’ – Says It Can 'Use Whatever Part' Of OpenShell It Wants

Equity

In an interview with CNBC, the Nvidia CEO said OpenAI’s leadership team, including Sam Altman, Greg Brockman, Sarah Friar and Nick Turley, “do a terrific job running the company.”


The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT

BOTZ offers diversified exposure to a robotics boom fueled by AI, humanoid robots and industrial automation, as the sector rapidly evolves.

PATH Stock Wrapped Its Worst Week In 4 Months: UiPath Wins Higher Price Targets, But Analysts Still Want AI Proof 

Wall Street remains cautious about whether AI can drive faster growth and stronger revenue for UiPath. 


BIDU Stock Up After AI Firm Opens Hong Kong Shares To Mainland China Investors

Shanghai officials added Baidu’s Hong Kong shares to Stock Connect, a trading link between mainland China and Hong Kong, Baidu said. 


Are Robots the New Normal? Bet on these ETFs to Invest in the Future

Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.

Why Is PATH Stock Tumbling Over 7% In Overnight Trading?

Strong results and higher guidance failed to offset valuation concerns and profit-taking after PATH’s historic August rally.


A Guide to Investing in AI ETFs

 AI ETFs offer diversified exposure to a fast-growing sector, but wide performance gaps show why fund selection and strategy matter.

XPEV Stock Rises 1.5% As CEO Takes First Robotaxi Ride In Guangzhou

The Chinese electric vehicle maker started closed testing of its robotaxi platform just eight months after unveiling the project at its 2025 AI Day.


Beyond Automotive: Healthcare Automation Drives the Next Leg for Robotics ETFs

Rising use of automation in healthcare is reshaping robotics ETFs as med-tech innovators gain prominence.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Bearish Sentiment

<ul class="summary-bullets"><li>Huang said Nvidia views AI development and AI safety as complementary efforts rather than competing priorities.</li><li>He described himself as “a responsible optimist” and said companies need to develop AI “safely” and “responsibly” while complying with existing laws.</li><li>The Nvidia CEO also warned against “regulatory capture” and said policymakers should avoid rules that could “suffocate the industry” while AI is still developing.</li></ul>Nvidia (NVDA) CEO Jensen Huang called OpenAI “one of the most consequential companies in history” Monday, defending the AI startup’s importance to Nvidia while leaving the door open for it to use any part of Nvidia’s newly launched OpenShell safety platform.“The thing that I have to decide in the case of OpenAI [is]: is OpenAI a great investment? And the answer, absolutely,” Huang said in a CNBC interview. “This is one of the most consequential companies in history.”Huang also praised OpenAI’s leadership, saying Sam Altman, Greg Brockman, Sarah Friar and Nick Turley “do a terrific job running the company,” adding that they are “incredible researchers” and that it is “a real privilege to work with them.”<a href="https://stocktwits.com/symbol/NVDA">NVDA stock</a> rose as much as 3.5% in morning trade and was among the top trending tickers on Stocktwits at the time of writing, while retail sentiment trended in ‘bearish’ territory over the past day. Before markets opened, Nvidia <a href="https://stocktwits.com/news-articles/markets/equity/nvda-stock-climbs-after-nvidia-approves-largest-buyback-increase-in-company-history/cZMSMQxRBQ1">announced</a> its board had authorized a $150 billion increase to its share repurchase program, bringing the remaining authorization to $235 billion.<figure class="image"><img src="https://news.stocktwits-cdn.com/edited_95acb2e8_c96a_486c_ad35_4a3b266a872918274982093036346943_302be633ae.jpg" alt="edited_95acb2e8-c96a-486c-ad35-4a3b266a872918274982093036346943.jpg" width="960" height="1552"><figcaption>NVDA stock retail sentiment on September 28 as of 9:45 a.m. ET | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Huang Leaves OpenAI Door Open On OpenShell</h2>The Nvidia CEO’s comments come after OpenAI was notably absent from the roughly 100 companies supporting&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-launches-open-agent-safety-platform-with-microsoft-anthropic-palantir-on-board/cZMSrgyRBQJ">Open Agent Safety Platform</a>, an open-source system Nvidia designed to contain and monitor AI agents. Asked whether that meant OpenAI was not cooperating, Huang said the platform was open to the company.“However they would like to participate is going to be super welcome,” Huang said. “They could look at the code. They could use whatever part of it they would like. They could build their own inspired by this, or they could use it.”<h2 class="st-heading-2">Jensen Huang Says AI Safety Should Not Slow Development</h2>Huang positioned OpenShell as part of a broader effort to make increasingly autonomous AI systems safer to deploy. He has argued that AI advancement and safety should not be treated as competing goals.“Accelerating AI and accelerating AI safety is the same idea,” he said, arguing that improvements in capability have also made AI more predictable, grounded and useful.He also warned against “regulatory capture,” saying policymakers should avoid rules that could “suffocate the industry” while AI is still developing.“I’m a responsible optimist,” Huang said, adding that companies must build the technology “safely” and “responsibly” while complying with existing laws and regulations.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvda-stock-climbs-after-nvidia-approves-largest-buyback-increase-in-company-history/cZMSMQxRBQ1">NVDA Stock Climbs After Nvidia Approves ‘Largest Buyback Increase’ In Company History</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In an interview with CNBC, the Nvidia CEO said OpenAI’s leadership team, including Sam Altman, Greg Brockman, Sarah Friar and Nick Turley, “do a terrific job running the company.”

Global X Funds - Global X Artificial Intelligence & Technology ETF

iShares Future AI & Tech ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

Roundhill Generative AI & Technology ETF

OpenAI

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Fundamentals

Info

BOTZ Global X Funds Global X Robotics & Artificial Intelligence ETF

Fundamentals

Latest BOTZ News